Janus Henderson Group’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,336,722
Closed -$11.7M 2708
2023
Q1
$11.7M Buy
1,336,722
+53,216
+4% +$492K 0.01% 680
2022
Q4
$10.2M Sell
1,283,506
-334,702
-21% -$2.1M 0.01% 722
2022
Q3
$7.79M Buy
1,618,208
+885,553
+121% +$5.56M ﹤0.01% 886
2022
Q2
$4.08M Buy
732,655
+95,887
+15% +$329K ﹤0.01% 878
2022
Q1
$3.22M Sell
636,768
-593,687
-48% -$4.76M ﹤0.01% 1104
2021
Q4
$15.8M Sell
1,230,455
-171,619
-12% -$2.45M 0.01% 836
2021
Q3
$20.5M Sell
1,402,074
-50,541
-3% -$862K 0.01% 791
2021
Q2
$21.5M Buy
+1,452,615
New +$25.5M 0.01% 769

Other funds holding RAIN

Janus Henderson Group's RAIN Position: Q2 2023 in Review

Janus Henderson Group sold out of Rain Oncology Inc. Common Stock (RAIN) in Q2 2023, closing a stake of 1,336,722 shares — an estimated $11.7M sold.

Janus Henderson Group first reported a position in RAIN in Q2 2021 and held it in 8 quarters. The position peaked at $21.5M in Q2 2021. 62 funds tracked by Wall St. Rank hold RAIN as of Q2 2023.

  • Janus Henderson Group reported no remaining Rain Oncology Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Janus Henderson Group sold 1,336,722 Rain Oncology Inc. Common Stock shares in Q2 2023, an estimated $11.7M.
  • Janus Henderson Group first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Janus Henderson Group's Rain Oncology Inc. Common Stock position peaked at $21.5M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q2 2023.

Based on Janus Henderson Group's 13F filing for Q2 2023, filed 14 Aug 2023.